Are Antibiotic Allergy Labels Costing Patients Options?
Antibiotic allergy delabeling is a crucial stewardship strategy that reduces resistance and improves patient outcomes nationwide. It's a process that involves re-evaluating and removing inaccurate labels of antibiotic allergies, which are surprisingly common and often incorrect.
The Problem with Inaccurate Labels
Antibiotic allergy labels, especially for beta-lactams like penicillin, are prevalent in healthcare settings. In high-income countries, up to 11.5% of adults report a penicillin allergy, and this rate can reach 35% in specific medical fields like hematology, oncology, and transplant medicine. However, a shocking 90% of these labels are inaccurate, leading to avoidable harm.
Patients with incorrect antibiotic allergy labels face increased risks of severe infections, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, surgical site infections, and prolonged hospital stays. They are also more likely to receive broad-spectrum antibiotics, which can contribute to antimicrobial resistance and make future treatments more challenging.
Antibiotic Allergy Delabeling in Action
Delabeling antibiotic allergies is a multidisciplinary effort involving infectious diseases physicians, antimicrobial stewardship pharmacists, internal medicine clinicians, and community providers. It involves structured risk stratification to differentiate between low-risk, patient-reported reactions and severe immunoglobulin E and T-cell-mediated reactions. This approach ensures safe evaluation, including supervised test dosing when necessary.
By implementing this coordinated strategy, healthcare providers can restore access to first-line beta-lactams, reduce unnecessary exposure to second-line antibiotics, and expedite the time to effective treatment. Correcting inaccurate labels also aligns with clinical guidelines, leading to better prescribing practices and fewer complications from suboptimal antibiotic choices.
Clinical Impact for U.S. Practice
Integrating antibiotic allergy delabeling into routine healthcare pathways can significantly enhance care quality and public health. Accurate allergy histories, standardized risk assessment tools, and clear referral criteria enable timely decisions during patient admissions, perioperative care, and outpatient treatment. As more patients are safely delabeled, clinicians can prescribe narrower-spectrum antibiotics with confidence, improve antimicrobial stewardship metrics, and combat antimicrobial resistance.
For infectious diseases specialists, antimicrobial stewardship pharmacists, and frontline internal and community medicine providers, antibiotic allergy delabeling offers a practical, evidence-based approach to restoring first-line therapies, optimizing patient outcomes, and minimizing preventable harm. This strategy empowers healthcare teams to address inaccurate labels systematically, ensuring patient safety and aligning with stewardship goals.
Reference:
Mitri EA et al. Executive Summary: State-of-the-Art Review: Antibiotic Allergy-A Multidisciplinary Approach to Delabeling. Clin Infect Dis. 2025;81(4):693-694.
Creative Commons Attribution-Non Commercial 4.0 License:
This article is available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.
